Allergan plc

 
Find more results for NYSE:WPI

Officers and directors

Brenton L. Saunders
Chairman of the Board, President, Chief Executive Officer
Maria Teresa Bernas Hilado
Chief Financial Officer, Executive Vice President
Karen Lee Ling
Chief Human Resource Officer, Executive Vice President
A. Robert D. Bailey
Executive Vice President, Chief Legal Officer and Corporate Secretary
William Meury
Executive Vice President and President, Branded Pharma
Paul Navarre
Executive Vice President and President, International Brands
Philippe Schaison
Executive Vice President and President, Allergan Medical
Robert A. Stewart
Executive Vice President and President, Generic and Global Operations
James C. D'Arecca
Chief Accounting Officer
Christopher J. Coughlin
Lead Independent Director

Address

Clonshaugh Business And Technology Park Coolock
DUBLIN, D17 E400
Ireland
+353-21-65235000 (Phone)

Website links

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of pharmaceutical products, medical aesthetics, biosimilar and over-the-counter (OTC) pharmaceutical products. Its segments are US Brands, US Medical Aesthetics and International Brands. The US Brands segment includes sales and expenses relating to branded products within the United States, including certain Botox therapies. The US Medical Aesthetics segment includes sales and expenses relating to aesthetics and dermatology products within the United States, including certain Botox therapies. The International Brands segment includes sales and expenses relating to products sold outside of the United States. It has rights to RST-001, a gene therapy approach for the treatment of retinitis pigmentosa (RP). It has global rights to AKN-083, a preclinical farnesoid X receptor (FXR) agonist for the treatment of non-alcoholic steatohepatitis (NASH).

Related companies

* Delayed by up to 20 minutes -  Disclaimer